predicting the drug release kinetics of matrix tablets · 8/9/2012 · predicting the drug release...
TRANSCRIPT
-
Results
Predicting the Drug Release Kinetics of MatrixTablets
Ami Radunskaya - Pomona College - Claremontwith Peter Hinow (UWM), Aisha Najera (CGU), Ezra Buchla
SIAM Life SciencesAugust 9, 2012
A. Radunskaya Release kinetics of matrix tablets
-
Results
Origin and Collaborators
Workshop on the Application of Mathematics to Problems inBiomedicine, December 17-19, 2007 at the University of Otago inDunedin, New Zealand
I Peter Hinow (University of Wisconsin, Milwaukee)
I Ian Tucker, Thomas Rades, Lipika Chatterjee (New Zealand’sNational School of Pharmacy)
I Boris Bäumer (Department of Mathematics and Statistics,University of Otago)
I Students: Chris duBois (PO ’07), Emma Spiro (PO ’07), TracyBacke (HMC ’08)
I Recent work: Aisha Najera (CGU), Ezra Buchla
A. Radunskaya Release kinetics of matrix tablets
-
Results
Origin and Collaborators
Workshop on the Application of Mathematics to Problems inBiomedicine, December 17-19, 2007 at the University of Otago inDunedin, New Zealand
I Peter Hinow (University of Wisconsin, Milwaukee)I Ian Tucker, Thomas Rades, Lipika Chatterjee (New Zealand’s
National School of Pharmacy)
I Boris Bäumer (Department of Mathematics and Statistics,University of Otago)
I Students: Chris duBois (PO ’07), Emma Spiro (PO ’07), TracyBacke (HMC ’08)
I Recent work: Aisha Najera (CGU), Ezra Buchla
A. Radunskaya Release kinetics of matrix tablets
-
Results
Origin and Collaborators
Workshop on the Application of Mathematics to Problems inBiomedicine, December 17-19, 2007 at the University of Otago inDunedin, New Zealand
I Peter Hinow (University of Wisconsin, Milwaukee)I Ian Tucker, Thomas Rades, Lipika Chatterjee (New Zealand’s
National School of Pharmacy)I Boris Bäumer (Department of Mathematics and Statistics,
University of Otago)
I Students: Chris duBois (PO ’07), Emma Spiro (PO ’07), TracyBacke (HMC ’08)
I Recent work: Aisha Najera (CGU), Ezra Buchla
A. Radunskaya Release kinetics of matrix tablets
-
Results
Origin and Collaborators
Workshop on the Application of Mathematics to Problems inBiomedicine, December 17-19, 2007 at the University of Otago inDunedin, New Zealand
I Peter Hinow (University of Wisconsin, Milwaukee)I Ian Tucker, Thomas Rades, Lipika Chatterjee (New Zealand’s
National School of Pharmacy)I Boris Bäumer (Department of Mathematics and Statistics,
University of Otago)I Students: Chris duBois (PO ’07), Emma Spiro (PO ’07), Tracy
Backe (HMC ’08)
I Recent work: Aisha Najera (CGU), Ezra Buchla
A. Radunskaya Release kinetics of matrix tablets
-
Results
Origin and Collaborators
Workshop on the Application of Mathematics to Problems inBiomedicine, December 17-19, 2007 at the University of Otago inDunedin, New Zealand
I Peter Hinow (University of Wisconsin, Milwaukee)I Ian Tucker, Thomas Rades, Lipika Chatterjee (New Zealand’s
National School of Pharmacy)I Boris Bäumer (Department of Mathematics and Statistics,
University of Otago)I Students: Chris duBois (PO ’07), Emma Spiro (PO ’07), Tracy
Backe (HMC ’08)I Recent work: Aisha Najera (CGU), Ezra Buchla
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sustained release (SR) tablets
Sustained release (SR) tablets are a common dosage form. TheyI release the drug over 12-24 hours
I may contain three times the dose of drug that is contained in animmediate release tablet
I need to be taken less often→ less chance of forgetting to take atablet
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sustained release (SR) tablets
Sustained release (SR) tablets are a common dosage form. TheyI release the drug over 12-24 hoursI may contain three times the dose of drug that is contained in an
immediate release tablet
I need to be taken less often→ less chance of forgetting to take atablet
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sustained release (SR) tablets
Sustained release (SR) tablets are a common dosage form. TheyI release the drug over 12-24 hoursI may contain three times the dose of drug that is contained in an
immediate release tabletI need to be taken less often→ less chance of forgetting to take a
tablet
A. Radunskaya Release kinetics of matrix tablets
-
Results
Formulation of sustained release tablets
A powder mixture consisting ofI drug
I excipient (inactive ingredient, water soluble) andI polymer (inactive ingredient, water insoluble)
is compressed in a die at high pressure (200 MPa). After compression,the tablet can be treated thermally ( 70◦C) for several hours.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Formulation of sustained release tablets
A powder mixture consisting ofI drugI excipient (inactive ingredient, water soluble) and
I polymer (inactive ingredient, water insoluble)
is compressed in a die at high pressure (200 MPa). After compression,the tablet can be treated thermally ( 70◦C) for several hours.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Formulation of sustained release tablets
A powder mixture consisting ofI drugI excipient (inactive ingredient, water soluble) andI polymer (inactive ingredient, water insoluble)
is compressed in a die at high pressure (200 MPa). After compression,the tablet can be treated thermally ( 70◦C) for several hours.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Possible thermal treatment of the tablet
Heating of the tablet causes the polymer to melt and to encapsulatethe soluble drug.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Release mechanismUpon placement in fluid (water or intestinal fluid of a patient), thepolymer matrix remains largely intact while fluid penetrates anddissolved drug and soluble excipient molecules diffuse out.
Field emission scanning electron microscope (SEM) image of amatrix tablet after dissolution of drug and excipient at 400×magnification.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Release profiles
Experimental tablets formulated from different powder mixture areplaced in water or phosphate buffer.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Adjustable parameters
During the production of the tablet one can varyI composition of the powder mixture
I applied curing temperature and durationI tablet sizeI powder particle sizes
A. Radunskaya Release kinetics of matrix tablets
-
Results
Adjustable parameters
During the production of the tablet one can varyI composition of the powder mixtureI applied curing temperature and duration
I tablet sizeI powder particle sizes
A. Radunskaya Release kinetics of matrix tablets
-
Results
Adjustable parameters
During the production of the tablet one can varyI composition of the powder mixtureI applied curing temperature and durationI tablet size
I powder particle sizes
A. Radunskaya Release kinetics of matrix tablets
-
Results
Adjustable parameters
During the production of the tablet one can varyI composition of the powder mixtureI applied curing temperature and durationI tablet sizeI powder particle sizes
A. Radunskaya Release kinetics of matrix tablets
-
Results
Adjustable parameters
During the production of the tablet one can varyI composition of the powder mixtureI applied curing temperature and durationI tablet sizeI powder particle sizes
Goal: We seek a tool to quantitatively predict the release kinetics andtheir dependence on these parameters.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Standard Release Formulas:
Power Law: R(t) = ktn. Diffusion: n = .5, Zero-order: n = 1.0.Peppas (Fickian + Relaxation Diffusion): R(t) = k1tm + k2t2m.Weibull: R(t) = 1− e−(t/tβ)β .
0 2 4 6 8 100
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
time (hrs
fract
ion
rele
ased
PeppasWeibull
A. Radunskaya Release kinetics of matrix tablets
-
Results
Three mathematical models
1. We develop a system of partial differential equations, where timeand space are treated as continuous variables.
2. We model the diffusion process as a random walk on a graphembedded in R3 whose vertices are generated from a randomsphere packing. 1
3. We create a cellular automaton model to capture more details ofthe spatial heterogeneity of the tablets.
1B. Baeumer, L. Chatterjee, P. Hinow, T. Rades, A. Radunskaya, and I. Tucker.Predicting the Drug Release Kinetics of Matrix Tablets. DCDS-B 12, No. 2, (2009)
A. Radunskaya Release kinetics of matrix tablets
-
Results
Three mathematical models
1. We develop a system of partial differential equations, where timeand space are treated as continuous variables.
2. We model the diffusion process as a random walk on a graphembedded in R3 whose vertices are generated from a randomsphere packing. 1
3. We create a cellular automaton model to capture more details ofthe spatial heterogeneity of the tablets.
1B. Baeumer, L. Chatterjee, P. Hinow, T. Rades, A. Radunskaya, and I. Tucker.Predicting the Drug Release Kinetics of Matrix Tablets. DCDS-B 12, No. 2, (2009)
A. Radunskaya Release kinetics of matrix tablets
-
Results
Three mathematical models
1. We develop a system of partial differential equations, where timeand space are treated as continuous variables.
2. We model the diffusion process as a random walk on a graphembedded in R3 whose vertices are generated from a randomsphere packing. 1
3. We create a cellular automaton model to capture more details ofthe spatial heterogeneity of the tablets.
1B. Baeumer, L. Chatterjee, P. Hinow, T. Rades, A. Radunskaya, and I. Tucker.Predicting the Drug Release Kinetics of Matrix Tablets. DCDS-B 12, No. 2, (2009)
A. Radunskaya Release kinetics of matrix tablets
-
Results
The continuous model
Let u1(r, z, t) be the concentration of dissolved excipient in thesolvent and let u2(r, z, t) be the concentration of undissolved excipientin the solid remainder of the tablet.
Likewise, denote by v1(r, z, t) and v2(r, z, t) the concentration ofdissolved drug in the solvent and the content of undissolved drug inthe tablet, respectively.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The continuous model
Let κ ∈ [0, 1] denote the porosity of the tablet, κ will increase as moreand more excipient and drug are dissolved in the solvent. Then κu1 isthe concentration of dissolved excipient in the tablet.
Assuming classical Fick’s law, the flux of dissolved excipient is givenby
Fluxsolved excipient = −Du(κ ∂∂r u1(r, z)κ ∂∂z u1(r, z)
),
where Du is the diffusion constant.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The continuous model
The conservation of mass equation yields
∂
∂t(κu1) = ∇(r,z) · (Duκ∇u1) + g(t),
where g(t) is the rate of concentration increase from dissolvingexcipient.
The higher the porosity, the higher the rate of dissolution. But the rateof dissolution saturates at a certain maximum concentration Cumax ofthe dissolved excipient.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The continuous model
Hence we assume that
g(t) = αuκ(
1− u1Cumax
)u2
and obtain the following system of evolution equations
∂
∂t(κ(u2, v2)u1)−∇(r,z) · (Duκ(u2, v2)∇u1)
= αuκ(u2, v2)(
1− u1Cumax
)u2,
∂
∂tu2 = −αuκ(u2, v2)
(1− u1
Cumax
)u2,
+ two similar equations for dissolved and undissolved drug v1 and v2.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The continuous model
The porosity κ(u2, v2) depends on the concentration of undissolvedexcipient and drug in the tablet,
κ(u2, v2) = κ(u2 + v2) = (κ0 − κend)u2 + v2u02 + v
02
+ κend,
where κ0 is the initial porosity and κend is the porosity of the tabletonce all the excipient and drug are dissolved. For example, κ0 ≈ 2 %,and κend ≈ 60 %.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The continuous model
The equations are completed by homogeneous Dirichlet boundaryconditions for u1 and v1
u1 = 0, v1 = 0
on ∂Ω, as any dissolved excipient or drug outside the tablet isimmediately carried away by the surrounding fluid.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Results from the continuous model
Release profiles predicted by the continuous model as the finalporosity κend varies. The dimensionless parameters used in thisexample are κ0 = 0.02, Du = 0.3, Dv = 0.5 αu = αv = 1.5 andCumax = C
vmax = u
02 = v
02 = 1.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The random walk on a random graph
We construct a random sphere packing, where each particle is asphere of a fixed radius. The centers of the spheres are the vertices ofa graph, with edges between particles that are close to each other inspace. Each vertex carries a label L : V → {D,P,X} that indicateswhether the sphere is a drug, polymer or excipient particle,respectively.
The heating of the tablet is modeled by removing edges. Thediffusion of the drug particles to the exterior of the tablet is modeledas a random walk on the random graph.
A. Radunskaya Release kinetics of matrix tablets
-
Results
The random walk on a random graph
Particle numbers: 60 180 360
A sample path through a schematic two-dimensional tablet from aninner particle to the edge. Small solid circles represent polymerparticles.
A. Radunskaya Release kinetics of matrix tablets
-
Results
How to create a random sphere packing?
We use the method suggested by Lubachevsky and Stillinger (1990)and Knott et al. (2001).
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 150 100 150 200 250 300
50
100
150
200
250
300
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 10150 100 150 200 250 300
50
100
150
200
250
300
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 20150 100 150 200 250 300
50
100
150
200
250
300
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 30150 100 150 200 250 300
50
100
150
200
250
300
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 40150 100 150 200 250 300
50
100
150
200
250
300
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 50150 100 150 200 250 300
50
100
150
200
250
300
A. Radunskaya Release kinetics of matrix tablets
-
Results
Sphere Packing in 2-d
DEMO: Lubachevsky-Stillinger algorithmm 50 spheres, 2 sizes.Spheres grow at a constant rate, Ri, depending on their size: fastergrowth for LARGER spheres.Collisions between spheres or with a wall are elastic, (marked withred dots).Calculations stop when packing density stops changing.
Collision 60150 100 150 200 250 300
50
100
150
200
250
300
STOP.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Results of the Lubachevsky and Stillinger protocol
(Left) 735 spheres of approximately equal radius, the packing densityis ≈ 0.54. (Right) 198 spheres, where 8 large spheres are about 4times bigger than the others. The packing density is ≈ 0.63.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Construction of the contact graph
Given the set of positions (xi)Ni=1 and radii (ri)Ni=1, we define the
graph G by joining vertices xi and xj if
|xi − xj| ≤ λ(ri + rj)
where λ ≥ 1 is a constant (such graphs are known as proximitygraphs). The heating process removes edges with a probability p andresults in the heated contact graph Ĝ.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Examples of contact graphs: 2d
Left: before heating; Right: after heating. Polymer edges arerepresented in red. Fusing of polymer particles after heatingcorresponds to removing red edges.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Examples of contact graphs: 3d
The proximity graphs before (left) and after (right) the heatingprocess, where edges are removed with a probability p = 0.3.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Random walks on the contact graph
On the heated contact graph Ĝ we perform random walks that startfrom each drug particle and end when an exterior vertex or themaximum number of steps, Nmax, is reached.
If the walker, representing a drug molecule, is situated at vertex vithen the probability of moving to the adjacent vertex vj is given by
p(i→ j) = cij
∑j∈N (i)
cij
−1 ,where N (i) be the set of vertices neighboring vertex vi.
cij = c− if j is of type P, cij = c+ >> c− otherwise.
A. Radunskaya Release kinetics of matrix tablets
-
ResultsLow Temp High Temp
Qualitative agreement, but we do not capture a change from convex toconcave observed in the experimental release profiles.
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approachParticles in the tablet are represented by a vertex in a threedimensional lattice.
Each vertex (cell) can be in one of five states:
d
h
• drug (D) (purple)• polymer (P) (red)• excipient (E) (green)• empty (V) (black)• water (W) (dark blue)further characterized by itsconcentration of excipient anddrug
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approachParticles in the tablet are represented by a vertex in a threedimensional lattice.
Each vertex (cell) can be in one of five states:
d
h
• drug (D) (purple)• polymer (P) (red)• excipient (E) (green)• empty (V) (black)• water (W) (dark blue)further characterized by itsconcentration of excipient anddrug
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approachParticles in the tablet are represented by a vertex in a threedimensional lattice.
Each vertex (cell) can be in one of five states:
d
h
• drug (D) (purple)• polymer (P) (red)• excipient (E) (green)• empty (V) (black)• water (W) (dark blue)further characterized by itsconcentration of excipient anddrug
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approachParticles in the tablet are represented by a vertex in a threedimensional lattice.
Each vertex (cell) can be in one of five states:
d
h
• drug (D) (purple)• polymer (P) (red)• excipient (E) (green)• empty (V) (black)• water (W) (dark blue)further characterized by itsconcentration of excipient anddrug
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approachParticles in the tablet are represented by a vertex in a threedimensional lattice.
Each vertex (cell) can be in one of five states:
d
h
• drug (D) (purple)• polymer (P) (red)• excipient (E) (green)• empty (V) (black)• water (W) (dark blue)further characterized by itsconcentration of excipient anddrug
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approach
A computational step consists of two sub-steps:
I dissolution step: updating the number of wet cellsI diffusion step: updating the concentrations of dissolved drug and
excipient
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approach
A computational step consists of two sub-steps:
I dissolution step: updating the number of wet cells
I diffusion step: updating the concentrations of dissolved drug andexcipient
A. Radunskaya Release kinetics of matrix tablets
-
Results
Cellular Automaton approach
A computational step consists of two sub-steps:
I dissolution step: updating the number of wet cellsI diffusion step: updating the concentrations of dissolved drug and
excipient
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Simulations
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Shape of the release curves that we want to obtain: we want to match
0 5
10 15 20 25 30 35 40 45 50
0 1 2 3 4 5 6 7 8
mas
s re
leas
ed [m
g]
time [h]
Release of Indomethacin (10%w/w) from Eudragit RLPO (x%w/w) [74MPa, 40°C] matrix containing Lactose MH {90-125um}, a brittle & water soluble excipient, using a rotating basket apparatus (100rpm) in phosphate buffer
(0.2M, 900ml, pH 7.2) at 37°C
10% 20% 30% 40% 50%
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Shape of the release curves that we want to obtain: we want to match
0 5
10 15 20 25 30 35 40 45 50
0 1 2 3 4 5 6 7 8
mas
s re
leas
ed [m
g]
time [h]
Release of Indomethacin (10%w/w) from Eudragit RLPO (x%w/w) [74MPa, 40°C] matrix containing Lactose MH {90-125um}, a brittle & water soluble excipient, using a rotating basket apparatus (100rpm) in phosphate buffer
(0.2M, 900ml, pH 7.2) at 37°C
10% 20% 30% 40% 50%
• trapping
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Shape of the release curves that we want to obtain: we want to match
0 5
10 15 20 25 30 35 40 45 50
0 1 2 3 4 5 6 7 8
mas
s re
leas
ed [m
g]
time [h]
Release of Indomethacin (10%w/w) from Eudragit RLPO (x%w/w) [74MPa, 40°C] matrix containing Lactose MH {90-125um}, a brittle & water soluble excipient, using a rotating basket apparatus (100rpm) in phosphate buffer
(0.2M, 900ml, pH 7.2) at 37°C
10% 20% 30% 40% 50%
• initial concavity
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Simulating compression and heating
Initialize
Initial Drug Cell 4 subcells, empty diagonals
Polymer Before Drug Before Polymer After Drug After
swap
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Simulating compression and heating
No Thermal Treatment With Thermal Treatment
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Simulating compression and heatingNo Thermal Treatment
With Thermal Treatment
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Simulating compression and heatingNo Thermal Treatment With Thermal Treatment
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Release curves with and without compression
10 % polymer 50% polymer
0 1 2 3 4 5 6 7 80
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time (hrs)
Perc
ent R
elea
sed
With Thermal TreatmentWithout Thermal Treatment
0 1 2 3 4 5 6 7 80
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time (hrs)
Perc
ent R
elea
sed
With Thermal TreatmentWithout Thermal Treatment
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Does a shell form at high polymer fractions?
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Shell formation slows release 30% polymer
0 2 4 6 8 10 12 140
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
No shellWith shell
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Too much of a shell can trap everything 50% polymer
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
With all this, we get fairly close agreement with data
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
time [h]
mas
s re
leas
ed [m
g]
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
time [h]
mas
s re
leas
ed [m
g]
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
With all this, we get fairly close agreement with data
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
time [h]
mas
s re
leas
ed [m
g]
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
time [h]
mas
s re
leas
ed [m
g]
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
With all this, we get fairly close agreement with data
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
time [h]
mas
s re
leas
ed [m
g]
0
5
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5 6 7 8
time [h]
mas
s re
leas
ed [m
g]
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
The ideal pill?
0 2 4 6 8 100
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
time (hrs)
perc
ent r
elea
sed
30% polymer, no thermal treatment
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
The ideal pill?
0 2 4 6 8 100
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
time (hrs)
perc
ent r
elea
sed
30% polymer, no thermal treatment
A. Radunskaya Release kinetics of matrix tablets
-
Results Simulations
Thanks for Listening!
and thanks to NSF Grant DMS-0737537.
A. Radunskaya Release kinetics of matrix tablets
ResultsSimulations